Researchers at UCLA Health have surgically implanted blind patients with the Second Sight Orion device to improve their visual perception. The Orion device is designed to boost the ability to navigate by restoring their ability to perceive objects and movement. The device converts images captured by a tiny video camera on top of sunglasses into […]
Biomet vet Serbousek to succeed Mason as Orthofix CEO | Personnel Moves, August 13, 2019
Orthofix (NSDQ:OFIX) last week named a successor for president & CEO Brad Mason in November, tapping Jon Serbousek as president of its spine business effective August 5. Mason is slated to retire Oct. 31; Serbousek, a 30-year medtech veteran with stints at Biomet, Medtronic (NYSE:MDT) and Johnson & Johnson (NYSE:JNJ) unit DePuy Orthopaedics, is due to […]
Second Sight beat The Street in Q2 despite $8.44m loss
Second Sight Medical (NSDQ:EYES) posted second-quarter results yesterday that beat both the sales and earnings forecasts on Wall Street as it accelerated its pivot toward manufacturing a new cortical implant. Citing the costs of reorganization, the Sylmar, Calif.-based company reported a loss of $8.44 million, or -0.07¢ per share, on sales of $1.28 million for […]
Second Sight accelerates Orion visual prosthesis dev, posts Q1 miss
Second Sight Medical (NSDQ:EYES) said yesterday that it plans to accelerate development and commercialization of its Orion visual cortical prosthesis system and posted first quarter earnings that missed expectations on Wall Street. Sylmar, Calif.-based Second Sight’s Orion is designed to connect the camera in a pair of eyeglasses with an implant that receives the camera signal […]
Second Sight Medical releases early feasibility data on Orion cortical implant
Second Sight Medical (NSDQ:EYES) today announced preliminary results from a small feasibility study of its Orion cortical implant, which is designed to give eyesight to the blind. Sylmar, Calif.-based Second Sight’s Orion is designed to connect the camera in a pair of eyeglasses with an implant that receives the camera signal and translates it to […]
Second Sight Medical closes $35m rights offering
Second Sight Medical (NSDQ:EYES) said today that it closed a $34.6 million rights offering. The Sylmar, Calif.-based company said that it received subscriptions for a total of 45.8 million units, with a final subscription price of 72.4¢ per unit. Second Sight said that entities controlled by board chair Gregg Williams acquired a total of 41.4 million […]
What should the Mann Foundation do next?
Dr. Robert Greenberg, the Mann Foundation’s new executive chairman, has ideas about where to take one of medtech’s top research and development outfits. He explained more at DeviceTalks West in December. The new executive chairman of the Alfred E. Mann Foundation for Scientific Research sees the foundation continuing its mission of developing devices for unmet medical needs. The foundation […]
Second Sight Medical wins final CMS reimbursement nod for Argus II
Second Sight Medical (NSDQ:EYES) said today that the Centers for Medicare & Medicaid Services finalized the outpatient payment rate for its Argus II retinal prosthesis system for the coming year. The Argus II induces visual perception in blind patients with retinitis pigmentosa by stimulating of the retina’s remaining cells with electrical pulses, which allows for the perception […]
Second Sight raises $4m
Second Sight Medical (NSDQ:EYES) said today it raised approximately $4 million in a private placement deal with entities owned by board chair Gregg Williams. The Sylmar, Calif.-based company said that it floated approximately 2.5 million shares of stock at $1.62 per share, which was the last reported sale price of its stock on the effective date. “This […]
Second Sight inks $5m private placement deal
Second Sight Medical (NSDQ:EYES) said today it inked a $5 million private placement deal with funds slated to support continued development and testing of its implantable visual prosthetic technology. The Los Angeles-based company said it is selling approximately 3.2 million shares of common stock at $1.55 per share to entities owned by its board chair Gregg […]
Second Sight shares down despite Q2 earnings beat
Shares in Second Sight Medical (NSDQ:EYES) fell today despite the opthalmalogical device maker beating loss per share expectations on Wall Street with its second quarter earnings results. The Los Angeles-based company posted losses of $8 million, or 12¢ per share, on sales of $1.9 million for the three months ended June 30, seeing losses grow 16.3% […]
MassDevice Network
@MassDevice
LinkedIn
YouTube